Title |
Ganglioside GD2-specific trifunctional surrogate antibody Surek demonstrates therapeutic activity in a mouse melanoma model
|
---|---|
Published in |
Journal of Translational Medicine, November 2012
|
DOI | 10.1186/1479-5876-10-219 |
Pubmed ID | |
Authors |
Peter Ruf, Beatrix Schäfer, Nina Eissler, Ralph Mocikat, Juergen Hess, Matthias Plöscher, Susanne Wosch, Ivonne Suckstorff, Christine Zehetmeier, Horst Lindhofer |
Abstract |
Trifunctional bispecific antibodies (trAb) are a special class of bispecific molecules recruiting and activating T cells and accessory immune cells simultaneously at the targeted tumor. The new trAb Ektomab that targets the melanoma-associated ganglioside antigen GD2 and the signaling molecule human CD3 (hCD3) on T cells demonstrated potent T-cell activation and tumor cell destruction in vitro. However, the relatively low affinity for the GD2 antigen raised the question of its therapeutic capability. To further evaluate its efficacy in vivo it was necessary to establish a mouse model. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Peru | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Science communicators (journalists, bloggers, editors) | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 33 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 7 | 21% |
Student > Ph. D. Student | 6 | 18% |
Other | 4 | 12% |
Researcher | 3 | 9% |
Professor | 2 | 6% |
Other | 5 | 15% |
Unknown | 6 | 18% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 11 | 33% |
Biochemistry, Genetics and Molecular Biology | 5 | 15% |
Immunology and Microbiology | 5 | 15% |
Medicine and Dentistry | 5 | 15% |
Engineering | 1 | 3% |
Other | 0 | 0% |
Unknown | 6 | 18% |